Joint health scores in a haemophilia A cohort from Pakistan with minimal or no access to factor VIII concentrate: correlation with thrombin generation and underlying mutation

被引:14
作者
Khanum, F. [1 ]
Bowen, D. J. [1 ]
Kerr, B. C. [1 ]
Collins, P. W. [1 ]
机构
[1] Cardiff Univ, Dept Haematol, Sch Med, Cardiff CF14 4XN, S Glam, Wales
关键词
haemophilia A; Pakistan; Gilbert score; thrombin generation; haemophilia joint health score; PROPHYLAXIS; CHILDREN; ARTHROPATHY; PLASMA; INHIBITOR; BOYS;
D O I
10.1111/hae.12326
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Haemophilia A is associated with recurrent joint bleeding which leads to synovitis and debilitating arthropathy. Coagulation factor VIII level is an important determinant of bleed number and development of arthropathy . The aim of this study was to compare the haemophilia joint health score (HJHS) and Gilbert score with severity, age, thrombin generation (TG) and underlying mutation in a haemophilia A cohort which had minimal access to haemostatic replacement therapy. Ninety-two haemophilia A individuals were recruited from Pakistan. Age, age at first bleed, target joints, haemophilic arthropathy joints, HJHS and Gilbert score were recorded. A strong correlation was found between HJHS and Gilbert score (r=0.98), both were significantly higher in severe (n=59) compared with non-severe (n=29) individuals before the age of 12years (P <= 0.01) but not thereafter. When individuals were divided according to developmental age (<12years, 12-16years and >16years), both HJHS and Gilbert score were significantly lower in the youngest group (P <= 0.001), there was no difference between 12-16years and >16years. In severe individuals there was no correlation between in vitro TG and joint score, whereas in non-severe individuals there was a weak negative correlation. In the severe group, no significant difference was observed for either joint score according to the underlying mutation type (inversion, missense, nonsense, frameshift). In this cohort of haemophilia A individuals with minimal access to haemostatic treatment, haemophilic arthropathy correlated with severity and age; among severe individuals, joint health scores did not relate to either the underlying mutation or in vitro TG.
引用
收藏
页码:426 / 434
页数:9
相关论文
共 27 条
[1]   A LONGITUDINAL-STUDY OF ORTHOPEDIC OUTCOMES FOR SEVERE FACTOR-VIII-DEFICIENT HEMOPHILIACS [J].
ALEDORT, LM ;
HASCHMEYER, RH ;
PETTERSSON, H ;
EIBL, H ;
GILBERT, M ;
HILGARTNER, M ;
KUNSHACK, M ;
LARRIEU, MJ ;
LEVINE, P .
JOURNAL OF INTERNAL MEDICINE, 1994, 236 (04) :391-399
[2]   Factors affecting the Haemophilia Joint Health Score in children with severe haemophilia [J].
Bladen, M. ;
Main, E. ;
Hubert, N. ;
Koutoumanou, E. ;
Liesner, R. ;
Khair, K. .
HAEMOPHILIA, 2013, 19 (04) :626-631
[3]   Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A [J].
Collins, P. W. ;
Blanchette, V. S. ;
Fischer, K. ;
Bjorkman, S. ;
Oh, M. ;
Fritsch, S. ;
Schroth, P. ;
Spotts, G. ;
Astermark, J. ;
Ewenstein, B. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (03) :413-420
[4]  
de Bosch NB, 2002, THROMB HAEMOSTASIS, V88, P253
[5]   Aerobic capacity in children with hemophilia [J].
Engelbert, Raoul H. H. ;
Plantnga, Martine ;
Van der Net, Janjaap ;
Van Genderen, Frank R. ;
Van den Berg, Marike H. ;
Helders, Paul J. M. ;
Takken, Tim .
JOURNAL OF PEDIATRICS, 2008, 152 (06) :833-838
[6]   Musculoskeletal measurement tools from the International Prophylaxis Study Group (IPSG) [J].
Feldman, B. M. ;
Funk, S. ;
Lundin, B. ;
Doria, A. S. ;
Ljung, R. ;
Blanchette, V. .
HAEMOPHILIA, 2008, 14 :162-169
[7]   Validation of a New Pediatric Joint Scoring System From the International Hemophilia Prophylaxis Study Group: Validity of the Hemophilia Joint Health Score [J].
Feldman, Brian M. ;
Funk, Sharon M. ;
Bergstrom, Britt-Marie ;
Zourikian, Nichan ;
Hilliard, Pamela ;
van der Net, Janjaap ;
Engelbert, Raoul ;
Petrini, Pia ;
van den Berg, H. Marijke ;
Manco-Johnson, Marilyn J. ;
Rivard, Georges E. ;
Abad, Audrey ;
Blanchette, Victor S. .
ARTHRITIS CARE & RESEARCH, 2011, 63 (02) :223-230
[8]  
Ferreira Adriana Aparecida, 2013, Rev. Bras. Hematol. Hemoter., V35, P23, DOI 10.5581/1516-8484.20130010
[9]  
Gerotziafas GT, THROMB J, V3, P16
[10]  
GILBERT MS, 1993, SEMIN HEMATOL, V30, P3